How Did Tempus AI Power Its Move to Positive EBITDA in Q3?
TEM hits its first positive adjusted EBITDA as strong Genomics and Data Licensing growth pairs with tighter cost discipline.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The aggressive growth fund investor was busy adding to some of her existing positions on Thursday.
TEM Continues to Strengthen Its Genomics Leadership With New Products
Tempus AI advances its genomics push with new assays, CDx progress and plans for whole-genome sequencing to drive future growth.
Cathie Dumps AMD And Reddit Shares Amid Tech Bloodbath, Ark Doubles Down On Tom Lee And Peter Thiel Crypto Plays - Advanced Micro Devices ( NASDAQ:AMD )
On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably involving Circle Internet Group Inc ( NYSE:CRCL ) , Bitmine Immersion Technologies Inc ( NYSE:BMNR ) , Bullish ( NYSE:BLSH ) , Advanced Micro Devices Inc ( NASDAQ:AMD ) , and Reddit Inc ( NYSE:RDDT ) .
Cathie Wood Goes Big On Alibaba With $25 Million Share Purchase, Scales Back On This Social Media Stock - Alibaba Gr Hldgs ( NYSE:BABA )
On Tuesday, Cathie Wood-led Ark Invest made significant moves in its portfolio, focusing on Alibaba Group Holding Ltd. ( NASDAQ:BABA ) , Baidu Inc. ( NASDAQ:BIDU ) , and Reddit Inc. ( NYSE:RDDT ) . These trades come amid a backdrop of evolving market dynamics and regulatory challenges, ...
Should You Buy, Hold or Sell TEM Stock Post Q3 Earnings Release?
Tempus AI posts first positive adjusted EBITDA and 84.7% revenue surge, signaling new growth momentum amid premium valuation.
Hims & Hers Expands AI-Driven Personalized and Subscription-Based Care
HIMS expands its AI-powered, subscription-based care model globally, backed by $870 million in fresh funding for growth.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The aggressive growth fund investor was busy adding to some of her existing positions on Thursday.
Tempus AI Growth Outlook Boosted By Higher ASPs, Pharma Contracts, Analyst Says - Tempus AI ( NASDAQ:TEM )
BTIG analyst Mark Massaro reiterated a Buy rating for Tempus AI, Inc. ( NASDAQ:TEM ) with a price target of $96 following the third-quarter FY25 earnings beat. On Nov. 4, Tempus AI reported revenue of $334.21 million, topping analyst estimates of $328.73 million and marking an 84.7% increase ...
TEM's Q3 Earnings & Revenues Beat, Stock Down in After-Market Hours
Tempus AI reports a narrower-than-expected Q3 loss and stronger revenues, raises full-year outlook, but shares decline following the results.
3 Growth Stocks to Invest $1,000 in Right Now
All of them are related to artificial intelligence, but none of them are likely to be upended by the popping of any AI bubble.
Tempus AI Stock ( TEM ) Slides 6% Overnight: Here's Why The Stock Is Trending - Tempus AI ( NASDAQ:TEM )
Tempus AI Inc. ( NASDAQ:TEM ) shares are trending on Wednesday. Check out the current price TEM of stock here. Shares of the healthcare technology company dropped 6.02% to $79.40 in after-hours trading on Tuesday following its third-quarter earnings report.
Tempus AI ( TEM ) Reports Q3 Loss, Tops Revenue Estimates
Tempus (TEM) delivered earnings and revenue surprises of +31.25% and +2.38%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Omnicell ( OMCL ) Q3 Earnings and Revenues Surpass Estimates
Omnicell (OMCL) delivered earnings and revenue surprises of +41.67% and +5.64%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
TEM vs. EXAS: Which Genomics Player Offers Greater Upside?
Tempus AI's soaring genomics revenues and Exact Sciences' diagnostic breakthroughs spotlight two distinct routes to precision oncology growth.
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $133B Cardiac Diagnostics Market
Designed for investors, board members, and CEOs, the latest PatentVest Pulse report offers a strategic view of who's leading and why in the rapidly evolving cardiac diagnostics market Designed for investors, board members, and CEOs, the latest PatentVest Pulse report offers a strategic view of ...
Behind the Scenes of Tempus AI's Latest Options Trends - Tempus AI ( NASDAQ:TEM )
Financial giants have made a conspicuous bearish move on Tempus AI. Our analysis of options history for Tempus AI ( NASDAQ:TEM ) revealed 16 unusual trades. Delving into the details, we found 25% of traders were bullish, while 68% showed bearish tendencies.
Tempus AI Enhances AI-Driven Diagnostics With Multiple FDA Approvals
TEM secures multiple FDA clearances in 2025, boosting its AI-driven diagnostic portfolio across oncology and cardiology.
AI in Biotechnology Market to Reach $11.4 Billion by 2030
Boston, Oct. 24, 2025 ( GLOBE NEWSWIRE ) -- Artificial intelligence ( AI ) is transforming biotechnology, from accelerating drug discovery and streamlining clinical trials to enhancing diagnostics and genomic research.
Ark Invest Dumps AMD Stock, Doubles Down On Chinese Tech Giants Alibaba And Baidu - ARK Fintech Innovation ETF ( BATS:ARKF ) , Advanced Micro Devices ( NASDAQ:AMD )
On Thursday, Cathie Wood's Ark Invest made significant trades involving Alibaba Group Holding Ltd ( NYSE:BABA ) , Baidu Inc ( NASDAQ:BIDU ) , Advanced Micro Devices Inc ( NASDAQ:AMD ) , and Tempus AI Inc ( NASDAQ:TEM ) .
Tempus AI's Options: A Look at What the Big Money is Thinking - Tempus AI ( NASDAQ:TEM )
Whales with a lot of money to spend have taken a noticeably bullish stance on Tempus AI. Looking at options history for Tempus AI ( NASDAQ:TEM ) we detected 9 trades. If we consider the specifics of each trade, it is accurate to state that 55% of the investors opened trades with bullish ...
Why Tempus AI Stock Raced More Than 5% Higher Today
The company, which specializes in artificial intelligence (AI) functionalities to aid drug discovery, could be a powerhouse, according to one market professional.
Tempus AI Shares Are Trading Higher Monday: What's Going On? - Tempus AI ( NASDAQ:TEM )
Tempus AI ( NASDAQ:TEM ) shares are trading higher Monday after the company announced its subsidiary, Ambry Genetics, published a peer reviewed study in Genetics in Medicine. TEM is delivering impressive returns. See what is driving the movement here.
Tempus AI Stock Before Q3 Earnings Release: To Buy or Not to Buy?
TEM's 48% surge, key FDA clearances and bold AI acquisitions set the stage for its Q3 earnings reveal.
Tempus AI Fuels Growth Through Strategic Biotech Collaborations
TEM expands its AI-driven growth with new collaborations in oncology, neurogenomics, and diagnostic innovation.
Whitehawk Therapeutics Dips Over 8% In After-Hours Trading Despite New Tempus AI Partnership - Whitehawk Therapeutics ( NASDAQ:WHWK )
Whitehawk Therapeutics Inc. ( NASDAQ:WHWK ) dropped 8.81% in after-hours trading Thursday, closing at $2.38, after announcing a multi-year collaboration with Tempus AI. Check out the current price of WHWK stock here. WHWK closed Thursday at $2.61, up 23.70% on the day, according to Benzinga ...
Hims & Hers Elevates Technology-Driven Healthcare Accessibility
HIMS boosts AI-led care with new technology chief, hormone therapies and a global push via its ZAVA acquisition.
Whitehawk Therapeutics Stock Is Trading Higher Thursday: What's Going On? - Whitehawk Therapeutics ( NASDAQ:WHWK )
Whitehawk Therapeutics, Inc. ( NASDAQ:WHWK ) shares are rising Thursday after the company announced a multi-year collaboration with Tempus AI Inc ( NASDAQ:TEM ) to support the development of its oncology pipeline. WHWK stock is racing ahead of the pack. Check the market position here.
SL Green Realty Corp. Reports Third Quarter 2025 EPS of $0.34 Per Share; and FFO of $1.58 Per Share
Financial and Operating Highlights ...
Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns - Apple ( NASDAQ:AAPL ) , Amazon.com ( NASDAQ:AMZN )
Ark Invest CEO Cathie Wood told investors the real AI revolution isn't in chatbots or self-driving cars, it's happening in hospitals and labs and Wall Street is largely overlooking it. Speaking at the All-In Summit 2025 in September, Wood highlighted healthcare as "the most profound application ...
NVDA & PLTR Driving AI in Health: Top Health IT Stocks for Q3 Earnings
NVDA and PLTR drive AI integration across healthcare, fueling optimism for Omnicell and Tempus AI's Q3 performance.
Smart Money Is Betting Big In TEM Options - Tempus AI ( NASDAQ:TEM )
Whales with a lot of money to spend have taken a noticeably bullish stance on Tempus AI. Looking at options history for Tempus AI ( NASDAQ:TEM ) we detected 49 trades. If we consider the specifics of each trade, it is accurate to state that 48% of the investors opened trades with bullish ...
Nancy Pelosi, Cathie Wood Align On These 4 Stocks - Do You Own Any? - ARK Fintech Innovation ETF ( BATS:ARKF ) , Amazon.com ( NASDAQ:AMZN )
Two of the most well-known female figures tracked by retail investors are former Speaker of the House Nancy Pelosi ( D-Calif. ) and Ark Funds founder Cathie Wood. When it comes to stocks owned by the two figures, they have four in common over the past five years.
TEM Expands Partnership With Northwestern Medicine Amid AI Boom
Tempus AI deepens its collaboration with Northwestern Medicine, embedding its AI co-pilot David directly into the health system's EHR to boost clinical efficiency.
Tempus AI Up Nearly 185% Since Nancy Pelosi's Reported Purchase In January 2025 - Tempus AI ( NASDAQ:TEM )
Investors who followed the stock market disclosures from former House Speaker Nancy Pelosi would have seen significant returns, as an investment in the artificial intelligence health company Tempus AI Inc. ( NASDAQ:TEM ) has surged in value.
Strategic Deals Drive TEM Growth Amid Competition: Buy, Hold or Sell?
Tempus AI sharpens its edge in precision medicine with key acquisitions, strong R&D launches, and improving financials amid rising competition.
Tempus AI's $100 Breakout - Billionaire Cliff Asness Reaps 60% Windfall - Tempus AI ( NASDAQ:TEM )
Tempus AI Inc ( NASDAQ:TEM ) has become one of 2025's most dramatic comeback stories. The stock soared past $100 this week, marking a new 52-week high and sending the market buzzing about the AI-powered cancer diagnostics company's growth prospects.
Tempus AI Executive Ryan Fukushima Sells $460,000 Worth Of Stock - Tempus AI ( NASDAQ:TEM )
Tempus AI Inc. ( NASDAQ:TEM ) shares are trending on Thursday. Check out the current price of TEM stock here. Shares of the health technology company inched up a little after the market closed on Wednesday, adding 0.20% to land at $103.46. That came on top of a solid performance during the ...
Nancy Pelosi's Tempus Play Might Be Smartest Trade In Washington - Stock Surges 200% - Tempus AI ( NASDAQ:TEM )
Tracking the financial-market trades of members of Congress might be the ultimate investor edge-especially with one AI stock in Nancy Pelosi's portfolio now up over 200% since she bought in.
What the Options Market Tells Us About Tempus AI - Tempus AI ( NASDAQ:TEM )
Deep-pocketed investors have adopted a bullish approach towards Tempus AI ( NASDAQ:TEM ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
A Closer Look at Tempus AI's Options Market Dynamics - Tempus AI ( NASDAQ:TEM )
Financial giants have made a conspicuous bullish move on Tempus AI. Our analysis of options history for Tempus AI ( NASDAQ:TEM ) revealed 48 unusual trades. Delving into the details, we found 45% of traders were bullish, while 27% showed bearish tendencies.
Why Tempus AI Stock Was Motoring Higher This Week
A recent acquisition seems to be paying off already for the tech-forward healthcare data specialist.
Tempus AI ( TEM ) Stock Is Rising Wednesday: What's Going On? - Tempus AI ( NASDAQ:TEM )
Shares of Tempus AI Inc ( NASDAQ:TEM ) are trading higher Wednesday, potentially building on momentum from last week given the lack of company-specific news. Here's what investors need to know.
What Are 2 Great Tech Stocks to Buy Right Now?
These two tech stocks could deliver big returns for investors willing to hold for the long term.
TEM vs. ILMN: Which Precision Oncology Stock Is Worth Buying Now?
As precision oncology advances, Tempus and Illumina lead the way with innovation. Which stock shows stronger growth momentum now?
Why Tempus AI Stock Is Plunging This Week
When a well-known growth investor decides to trim her position in a stock, investors sit up and take note.
Smart Money Is Betting Big In TEM Options - Tempus AI ( NASDAQ:TEM )
Financial giants have made a conspicuous bearish move on Tempus AI. Our analysis of options history for Tempus AI ( NASDAQ: TEM ) revealed 34 unusual trades. Delving into the details, we found 44% of traders were bullish, while 50% showed bearish tendencies.
Cathie Wood Makes Trading Blitz: Buys Alibaba Stock Worth $11 Million, Dumps AMD And This AI Stock ( CORRECTED ) - Alibaba Gr Hldgs ( NYSE:BABA )
Editor's Note: The story's headline has been updated to correct a typo. On Wednesday, Cathie Wood-led Ark Invest executed significant trades involving Alibaba Group Holding Ltd BABA, Advanced Micro Devices Inc. AMD, and Tempus AI Inc. TEM. ARK Innovation ETF ARKK fund purchased 63,231 shares of ...
Cathie Wood Makes Trading Blitz: Buys Alibaba Stock Woth $11 Million, Dumps AMD And This AI Stock - Alibaba Gr Hldgs ( NYSE:BABA )
On Wednesday, Cathie Wood-led Ark Invest executed significant trades involving Alibaba Group Holding Ltd BABA, Advanced Micro Devices Inc. AMD, and Tempus AI Inc. TEM. ARK Innovation ETF ARKK fund purchased 63,231 shares of Alibaba Group.
Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead - Tempus AI ( NASDAQ:TEM )
On Tuesday, Cathie Wood-led Ark Invest made a notable decision by selling shares of Tempus AI Inc. TEM, marking a significant move in their investment strategy.
